cloned into cho expression vector pcdna3.4 (Thermo Fisher)
90
Structured Review
Thermo Fisher
cloned into cho expression vector pcdna3.4
Cloned Into Cho Expression Vector Pcdna3.4, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcdna3%2E4+expression+vector/pmc11680381-129-19-23
Average 90 stars, based on 1 article reviews
Cloned Into Cho Expression Vector Pcdna3.4, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcdna3%2E4+expression+vector/pmc11680381-129-19-23
Average 90 stars, based on 1 article reviews
cloned into cho expression vector pcdna3.4 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Synthesized:Article Title: A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases Article Snippet: Gene fragments encoding antibody heavy chain (HC) and light chain (LC) were synthesized by Genewiz (South Plainfield, NJ) or IDT (Coralville, IA) and cloned into Article Title: The Effects of Aβ 1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2 Article Snippet: The cDNA encoding the antibody sequence was cloned into a Article Title: Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses Article Snippet: The variable regions coding sequences were cloned into a Article Title: Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies. Article Snippet: The DNA was then ligated into Article Title: Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model. Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan Article Snippet: The extracellular domain of ACE2 (NCBI, NM_021804.3, 1–708 AA) was cloned from cDNA of human PBMCs into the Clone Assay:Article Title: A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases Article Snippet: Gene fragments encoding antibody heavy chain (HC) and light chain (LC) were synthesized by Genewiz (South Plainfield, NJ) or IDT (Coralville, IA) and cloned into Article Title: The Effects of Aβ 1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2 Article Snippet: The cDNA encoding the antibody sequence was cloned into a Article Title: Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses Article Snippet: The variable regions coding sequences were cloned into a Article Title: Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies. Article Snippet: The DNA was then ligated into Article Title: Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model. Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan Article Snippet: The extracellular domain of ACE2 (NCBI, NM_021804.3, 1–708 AA) was cloned from cDNA of human PBMCs into the Expressing:Article Title: A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases Article Snippet: Gene fragments encoding antibody heavy chain (HC) and light chain (LC) were synthesized by Genewiz (South Plainfield, NJ) or IDT (Coralville, IA) and cloned into Article Title: The Effects of Aβ 1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2 Article Snippet: The cDNA encoding the antibody sequence was cloned into a Article Title: Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses Article Snippet: The variable regions coding sequences were cloned into a Article Title: Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies. Article Snippet: The DNA was then ligated into Article Title: Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model. Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan Article Snippet: The extracellular domain of ACE2 (NCBI, NM_021804.3, 1–708 AA) was cloned from cDNA of human PBMCs into the Plasmid Preparation:Article Title: A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases Article Snippet: Gene fragments encoding antibody heavy chain (HC) and light chain (LC) were synthesized by Genewiz (South Plainfield, NJ) or IDT (Coralville, IA) and cloned into Article Title: The Effects of Aβ 1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2 Article Snippet: The cDNA encoding the antibody sequence was cloned into a Article Title: Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses Article Snippet: The variable regions coding sequences were cloned into a Article Title: Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies. Article Snippet: The DNA was then ligated into Article Title: Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model. Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan Article Snippet: The extracellular domain of ACE2 (NCBI, NM_021804.3, 1–708 AA) was cloned from cDNA of human PBMCs into the Modification:Article Title: A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases Article Snippet: Gene fragments encoding antibody heavy chain (HC) and light chain (LC) were synthesized by Genewiz (South Plainfield, NJ) or IDT (Coralville, IA) and cloned into Article Title: The Effects of Aβ 1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2 Article Snippet: The cDNA encoding the antibody sequence was cloned into a Article Title: Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses Article Snippet: The variable regions coding sequences were cloned into a Article Title: Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies. Article Snippet: The DNA was then ligated into Article Title: Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model. Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan Article Snippet: The extracellular domain of ACE2 (NCBI, NM_021804.3, 1–708 AA) was cloned from cDNA of human PBMCs into the Sequencing:Article Title: A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases Article Snippet: Gene fragments encoding antibody heavy chain (HC) and light chain (LC) were synthesized by Genewiz (South Plainfield, NJ) or IDT (Coralville, IA) and cloned into Article Title: The Effects of Aβ 1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2 Article Snippet: The cDNA encoding the antibody sequence was cloned into a Article Title: Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses Article Snippet: The variable regions coding sequences were cloned into a Article Title: Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies. Article Snippet: The DNA was then ligated into Article Title: Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model. Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan Article Snippet: The extracellular domain of ACE2 (NCBI, NM_021804.3, 1–708 AA) was cloned from cDNA of human PBMCs into the Purification:Article Title: A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases Article Snippet: Gene fragments encoding antibody heavy chain (HC) and light chain (LC) were synthesized by Genewiz (South Plainfield, NJ) or IDT (Coralville, IA) and cloned into Article Title: The Effects of Aβ 1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2 Article Snippet: The cDNA encoding the antibody sequence was cloned into a Article Title: Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses Article Snippet: The variable regions coding sequences were cloned into a Article Title: Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies. Article Snippet: The DNA was then ligated into Article Title: Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model. Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan Article Snippet: The extracellular domain of ACE2 (NCBI, NM_021804.3, 1–708 AA) was cloned from cDNA of human PBMCs into the FLAG-tag:Article Title: A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases Article Snippet: Gene fragments encoding antibody heavy chain (HC) and light chain (LC) were synthesized by Genewiz (South Plainfield, NJ) or IDT (Coralville, IA) and cloned into Article Title: The Effects of Aβ 1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2 Article Snippet: The cDNA encoding the antibody sequence was cloned into a Article Title: Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses Article Snippet: The variable regions coding sequences were cloned into a Article Title: Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies. Article Snippet: The DNA was then ligated into Article Title: Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model. Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients Article Snippet: Briefly, the extracellular domain of ACE2 was inserted into the Article Title: Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan Article Snippet: The extracellular domain of ACE2 (NCBI, NM_021804.3, 1–708 AA) was cloned from cDNA of human PBMCs into the |